Harvard School of Public Health: Moderna Vaccine Slightly More Effective Than Pfizer Vaccine in Preventing COVID-19 Infection, Hospitalization, and Death
December 02, 2021
December 02, 2021
BOSTON, Massachusetts, Dec. 2 (TNSJou) -- Harvard University's T.H. Chan School of Public Health issued the following news release:
* * *
Both vaccines are highly effective and either one is strongly recommended
* * *
Compared with the Pfizer COVID-19 vaccine, the Moderna COVID-19 vaccine has a slightly lower risk of COVID-19 outcomes, including documented SARS-CoV-2 infection, symptomatic COVID-19, and COVID-19-related hospitalization, . . .
* * *
Both vaccines are highly effective and either one is strongly recommended
* * *
Compared with the Pfizer COVID-19 vaccine, the Moderna COVID-19 vaccine has a slightly lower risk of COVID-19 outcomes, including documented SARS-CoV-2 infection, symptomatic COVID-19, and COVID-19-related hospitalization, . . .